Spironolactone OGB 25 mg

Myanmar • Dexa Medica

Indication

Spironolactone is indicated in the management of:

  • Primary hyperaldosteronism for diagnostic and treatment of primary hyperaldosteronism
  • Edematous conditions for patients with congestive heart failure, cirrhosis of the liver accompanied by edema and/or ascites, and nephrotic syndrome
  • Essential hypertension

Composition

Spironolactone 25 mg

Package

10 strips of 10 tablets

Dosage Forms

Tablet

ATC Classification

C03D

Warning

Alcohol
Not Recommended
This item should not be used with alcohol.
Machinery
Not Recommended
This item should not be used while operating heavy machinery.
Pregnancy
Caution
This item may not be safe for use during pregnancy. Use with caution and after consultation with your doctor.
Lactation
Not Recommended
This item is not safe for use during lactation.

Dosage

0 to 18 Years Old

Safety and effectiveness in pediatric patients have not been established.

18 Years Old and Above

Diagnosis and treatment of primary hyperaldosteronism
If it takes a long time to perform the test:
400 mg/day for 3-4 weeks.

If it takes a short time to perform the test:
400 mg/day for 4 days.

Edematous conditions
Cardiac edema:
50-100 mg/day in single or divided doses.

Edema caused by cirrhosis of the liver with or without ascites:
300-600 mg/day.

Edema caused by nephrotic syndrome:
Usually 100-200 mg/day.

Essential hypertension
Initial dose 25 mg/day then increase to 100 mg/day in single or two divided doses. Dosage should be adjusted to blood pressure and potassium serum level.

See All Products